Munich - Delayed Quote EUR
Iovance Biotherapeutics Inc (2LB.MU)
2.0810
+0.1408
+(7.26%)
As of 8:00:57 AM GMT+2. Market Open.
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 2LB.MU | -- | -- | -- | -- |
| S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
| Downgrade | UBS: Buy to Neutral | 5/16/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 5/12/2025 |
| Maintains | Mizuho: Outperform to Outperform | 5/12/2025 |
| Maintains | Barclays: Overweight to Overweight | 5/12/2025 |
| Downgrade | JMP Securities: Market Outperform to Market Perform | 5/9/2025 |
| Maintains | Chardan Capital: Buy to Buy | 5/9/2025 |
Related Tickers
N04.MU Nucana PLC R
0.1410
+9.30%
N04.SG Nucana PLC (ADRs)
0.1490
+35.45%
N04.BE Nucana PLC R
0.1490
+74.27%
N04.F NuCana plc
0.1570
+3.29%
NKGNW NKGen Biotech, Inc.
0.0800
-15.79%
PHRM.CN PharmaTher Holdings Ltd.
0.2150
-2.27%
LIPO Lipella Pharmaceuticals Inc.
2.8850
+0.17%
TYRA Tyra Biosciences, Inc.
10.37
-3.17%
NKGN NKGen Biotech, Inc.
0.3400
+2.72%
PHRRF PharmaTher Holdings Ltd.
0.1534
-4.12%